Review Article
Other versions:
- ContentsContents
- Article InfoArticle Info
- CiteCite
- MetricsMetrics
- CommentComment
- RelatedRelated
- FigsFigs
- TabsTabs
- TaxaTaxa
- RefsRefs
- CitedCited
-
Article title
-
Abstract
-
Key words
-
1.0 Introduction
-
2.0 Epidemiology
-
3.0 Etiology & risk factors
-
4.0 Systemic manifestations associated with cutaneous sarcoidosis
-
5.0 Pathomechanisms
-
5.1 Overview
-
5.2 Molecular mechanisms
-
-
6.0 Clinical manifestation of cutaneous sarcoidosis
-
6.1 Papular and nodular sarcoidosis
-
6.2 Subcutaneous sarcoidosis (Figure )
-
6.3 Plaques sarcoidosis
-
6.4 Lupus pernio
-
6.5 Ichthyosiform, atrophic, ulcerated sarcoidosis
-
6.6 Mucosal sarcoidosis
-
6.7 Hair/nail associated sarcoidosis
-
6.8 Erythrodermic sarcoidosis (Figure )
-
6.9 Tattoo-, scar-, and trauma-associated cutaneous sarcoidosis
-
-
6.10 Drug-induced granuloma formation of the sarcoidosis type
-
6.11 Non-specific cutaneous lesions and sarcoidosis syndromes
-
-
7.0 Accompanying symptoms
-
8.0 Differential diagnoses
-
9.0 Diagnosis
-
9.1 Laboratory tests
-
9.2 Imaging and further diagnostics
-
9.3 Histopathology
-
-
10.0 Therapy
-
10.1 Local therapy
-
10.2 Systemic therapy
-
10.3 Glucocorticoids
-
10.4 Tetracyclines
-
10.5 Hydroxychloroquine
-
10.6 Phosphodiesterase inhibitors
-
10.7 Methotrexate
-
10.8 TNF-alpha inhibitors
-
10.9 Emerging treatments
-
-
11.0 Prognosis
-
12.0 Conclusion
-
Acknowledgements
-
Additional information
-
Conflict of interest
-
Ethical statements
-
Use of AI
-
Funding
-
Author contributions
-
Data availability
-
-
References
Subscribe to email alerts for current Article's categories